Welcome to the Delaware Society for Clinical Oncology

Forgot password

Events

Upcoming events

  • 2019 San Antonio Breast Cancer Symposium Review

    • 06 Feb 2020
    • 6:00 PM - 8:00 PM
    • Harry's Savoy Grill - Ballroom (2020 Naamans Road, Wilmington, DE 19810)

    This educational activity will be presented by Jennifer Matro, MD, Assistant Professor of Clinical Medicine, Division of Hematology Oncology, University of Pennsylvania Perelman School of Medicine.  

     

    THIS EVENT IS NOT OPEN TO THE PUBLIC.



    Show details

  • ASH 2019 Update

    • 19 Mar 2020
    • 6:00 PM - 8:00 PM
    • TBD

    This educational activity will be presented by Alfred Garfall, MD, MS, Assistant Professor of Medicine at the Hospital of the University of Pennsylvania.


    THIS EVENT IS NOT OPEN TO THE PUBLIC.



    Show details

  • (Topic) Microbiota and cancer metastases

    • 02 Apr 2020
    • 6:00 PM - 8:00 PM
    • TBD

    This educational activity will be presented by Heidi Nelson, MD, Medical Director of American College of Surgeons (ACS) Cancer Programs. 


    THIS EVENT IS NOT OPEN TO THE PUBLIC.


    Show details

  • Gut Microbiome and Environmental Colon Cancer - the missing link?

    • 02 Apr 2020
    • 6:00 PM - 8:00 PM
    • TBC

    This educational activity will be presented by Heidi Nelson, MD, Medical Director, Cancer Programs at the American College of Surgeons (ACS) Division of Research and Optimal Patient Care (DROPC).

    THIS EVENT IS NOT OPEN TO THE PUBLIC.



    Show details

Past events

04 Nov 2019 Radiation to convert the tumor into an in situ vaccine
24 Oct 2019 Clinical Overview of LUTATHERA® (lutetium Lu 177 dotatate)
10 Oct 2019 Mini symposium on Liver-Directed therapy with 90Y Microspheres
05 Sep 2019 Oligometastatic Prostate Cancer: Options and Evidence
19 Jun 2019 ASCO 2019: GI Oncology Review
11 Apr 2019 The Current and Future Role of PARP Inhibition in the Management of Ovarian Cancer
28 Feb 2019 2018 San Antonio Breast Cancer Symposium Review
31 Jan 2019 Venclexta in CLL and AML
08 Nov 2018 Orienteering on the Complex Treatment Landscape for EGFR Mutant NSCLC: Latest Evidence to Guide Clinical Decisions in Everyday Community Practice
24 Oct 2018 Molecular Tumor Boards: One Size Does Not Fit All
25 Sep 2018 Immunotherapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer Following Chemoradiation Therapy
06 Sep 2018 Best Practice for Inflammatory Breast Cancer (IBC)
24 Jul 2018 Immunotherapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer Following Chemoradiation Therapy
07 Jun 2018 Targeting Multiple Mechanisms of Cancer Immune Evasion
23 May 2018 Oncotype DX AR-V7 Nucleus Detect Program
10 May 2018 New Agent for Extended Adjuvant Therapy for HER2+ Breast Cancer Patients
26 Apr 2018 Categorizing the Molecular Heterogeneity of Acute Myeloid Leukemia
12 Apr 2018 New Treatments in Indolent Lymphomas
28 Mar 2018 Paving the Path to Precision Medicine in NSCLC: Using Biomarkers to Determine Treatment Course
01 Mar 2018 New Agents and Emerging Strategies in the Management of Early and Advanced Breast Cancer
01 Feb 2018 2017 San Antonio Breast Cancer Symposium Review
11 Jan 2018 From Biologics to Biosimilars in Oncology Practice: A New Source of Value
02 Nov 2017 Emerging Perspectives in Cancer Biomarkers
19 Oct 2017 CAR T Cell Therapies in Hematologic Malignancies
05 Oct 2017 Emerging Perspectives in Cancer Immunotherapy
21 Sep 2017 Beyond the Guidelines: Clinical Investigators Provide Perspectives on Biomarker-Guided Decision-Making for Patients with Non-Small Cell Lung Cancer
07 Sep 2017 Prostate Cancer Heterogeneity: Clinical Implications
08 Jun 2017 Recently Approved and Emerging Strategies in the Management of Gastrointestinal Cancers
18 May 2017 Pancreatic Cancer: New Horizons
27 Apr 2017 Why Novel Local Therapies are Essential for Systemic Cancer Cures
06 Apr 2017 Investigating the Potential of Immuno-Oncology Research
09 Mar 2017 The ACA: How Its Changing Health Care
12 Jan 2017 2016 San Antonio Breast Cancer Symposium Update
01 Dec 2016 Using Genomics to Improve Active Surveillance
10 Nov 2016 Uterine Leiomyosarcomas: Breaking the Code
13 Oct 2016 Locally Advanced and Metastatic Bladder Cancer Management
29 Sep 2016 Management of Multiple Myeloma in the Community Setting
01 Sep 2016 Integrating the 4th Modality: Immunotherapy for HNSCC
19 May 2016 The Molecular Basis of Cancer - Breast (MBOC)
05 May 2016 ASCO GI Highlights
21 Apr 2016 Targeting the Immune System to Improve Patient Outcomes in Advanced NSCLC
24 Mar 2016 Update on Precision Medicine: Identifying Opportunities and Overcoming Obstacles
25 Feb 2016 2015 San Antonio Breast Cancer Symposium Update
04 Feb 2016 Emerging Strategies in Newly Diagnosed and Relapsed/Refractory Hodgkin Lymphoma
10 Dec 2015 NRG Oncology Update
12 Nov 2015 Topic - advances in RX for treating severe cancer pain
22 Oct 2015 Advances in Immune Therapy: Checkpoint Blockade and Radiotherapy
21 May 2015 Updates in Hematology 2015
23 Apr 2015 Can Understanding the Biology of Lymphoma Aid Patient Management?
16 Apr 2015 Multiple Myeloma- Biology, Evolution & Minimal Residual Disease
02 Apr 2015 The Molecular Basis of Cancer Immunotherapy
12 Mar 2015 Optimizing Radiotherapy for High Risk Prostate Cancer
12 Feb 2015 Oncology Exchange: Evolving Treatment Strategies for Mantle Cell Lymphoma in Elderly and Heavily Pretreated Patients
22 Jan 2015 2014 San Antonio Breast Cancer Symposium Update
13 Nov 2014 Clinical Trials Portfolio of the NCI Head and Neck Steering Committee
23 Oct 2014 Multiple Myeloma 2014
25 Sep 2014 Contemporary Issues in Soft Tissue Sarcoma
12 Jun 2014 Evidence-based Management of Metastatic Colorectal Cancer in the Community
22 May 2014 Emerging Genetic Tests for Localized Prostate Cancer: Ready for Prime Time?
13 May 2014 Genomic Tests for Breast Cancer: Fact, Myth & Everything in Between
08 May 2014 A Case Study Discussion of Multiple Myeloma Management
29 Apr 2014 Sarcoma Management Update
20 Mar 2014 2013 San Antonio Breast Cancer Symposium Update
27 Feb 2014 Cancer Genomic Profiling: What a Clinician Needs to Know
30 Jan 2014 Health Reform - Challenges of Implementation
12 Dec 2013 Expanding the Boundaries of Treatment of Patients with mCRC after Previous Therapies have Failed”
19 Nov 2013 Clinical Discussion of TAFLINAR (dabrafenib)
14 Nov 2013 Molecular Basis of Breast Cancer: Fundamental and Evolving Concepts
02 Oct 2013 Pancreatic Cancer Update 2013
12 Sep 2013 Multiple Myeloma Update 2013
05 Jun 2013 Considerations for the Development and Management of Clinical Pathways
16 May 2013 Molecular Biomarkers in Cancer
09 Apr 2013 New Approaces to the Management of DCIS
07 Mar 2013 Radiation Therapy in Non-Hodgkin Lymphoma: New Role, New Rules
17 Jan 2013 2012 San Antonio Breast Cancer Symposium Update
06 Dec 2012 "Gene Expression-Based Diagnostics for Molecular Cancer Classification of Difficult to Diagnose Tumors"
15 Nov 2012 Controversies in the Management of DCIS of the Breast
04 Oct 2012 Art of Active Listening: Delivering Emotional Charged News
20 Sep 2012 The Molecular Basis of Lung Cancer
31 May 2012 "The Value of FDG PET/CT Imaging in Oncology: Good, Better, Best Practice"
05 Apr 2012 "Advances in the Management of Colorectal Liver Metastasis"
07 Mar 2012 "Gastrointestinal Stromal Tumors (GISTs): Considerations for Surgeons" and "A Multidisciplinary Case Study on Gastrointestinal Stromal Tumors"
29 Feb 2012 Current Trends in the Adjuvant Treatment of Newly Diagnosed Node-Positive Melanoma
12 Jan 2012 2011 San Antonio Breast Cancer Symposium Update
03 Nov 2011 "Recent Advances in the Treatment of Metastatic Melanoma"
05 Oct 2011 "New Updates in the Treatment of Metastatic Prostate Cancer"
20 Sep 2011 "Case Studies in Metastatic Breast Cancer"
12 May 2011 Molecular Basis of Cancer
03 Mar 2011 "2010 San Antonio Breast Cancer Symposium Update"

Delaware Society for Clinical Oncology
c/o Megan Hayes
Medical Society of Delaware
900 Prides Crossing, Newark, Delaware 19713
Tel: 302-224-5181, Fax: 302-366-1354, Email: Megan.Hayes@medsocdel.org

This website brought to you by:

 

Terms and Conditions of Use

 Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds

Powered by Wild Apricot Membership Software